The Global Market for Next-Generation Sequencing Tests Continues Its Torrid Pace

Area of Science:

• Genomics and Bioinformatics
• Healthcare Market Analysis
• Biotechnology Trends

Background:

• The market for next-generation sequencing (NGS) technologies has experienced significant growth.
• Healthcare decision-makers require empirical data on market trends for strategic planning.
• Limited published research exists on the specific nature and scale of NGS market trends.

Purpose of the Study:

• To provide a snapshot of next-generation sequencing market trends up to 2020.
• To analyze the growth and size of the clinical NGS services market.
• To identify key market segments and geographical trends in NGS adoption.

Main Methods:

• Market analysis of the global clinical NGS services sector.
• Forecasting market size from 2015 to 2020.
• Segmentation of the NGS market by application (e.g., reproductive health, oncology) and test type (e.g., gene panels, exome, genome sequencing).

Main Results:

• The global clinical NGS services market was valued at $2.2 billion in 2015 and forecasted to reach $7.7 billion by 2020.
• The reproductive health NGS test market is the largest segment, followed by oncology.
• Markets are demonstrating rapid growth in countries outside the United States.
• Tests sequencing more than 50 genes, but not the entire exome or genome, represent the largest market share.

Conclusions:

• The clinical NGS market is experiencing substantial growth, with significant expansion projected through 2020.
• Reproductive health and oncology are leading market segments for NGS tests.
• International markets, particularly outside the US, are showing rapid growth.
• Addressing key issues will be crucial for sustaining and facilitating appropriate future growth in the NGS market.